Antibodies to OX-2/CD200 and uses thereof

Details for Australian Patent Application No. 2007207764 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Kretz-Rommel, Anke; Springhorn, Jeremy P.; Bowdish, Katherine S.; McKnight, Susan Faas; Wu, Dayang

Agent Shelston IP

Pub. Number AU-B-2007207764

PCT Pub. Number WO2007/084321

Priority 60/759,085 12.01.06 US; 60/758,426 12.01.06 US; 60/801,991 18.05.06 US

Filing date 11 January 2007

Wipo publication date 26 July 2007

Acceptance publication date 7 June 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/084321 Priority application(s): WO2007/084321

18 September 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Kretz-Rommel, Anke; Springhorn, Jeremy P.; Bowdish, Katherine S.; McKnight, Susan Faas and Wu, Dayang

7 June 2012 Application Accepted

  Published as AU-B-2007207764

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007207767-Method of reverse link dynamic power control in a wireless communication system using quality feedback from a delay-sensitive traffic stream or overhead channel

2007207756-Wound shield for exudate management